Johnson & Johnson executives, on a Wednesday earnings call, did not provide a timeline for when U.S. Varipulse cases will restart after halting procedures in early January.
Szyman led Edwards Lifesciences’ critical care unit for more than a decade before BD acquired the group last year. Her ...
New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain ...
The rescinded orders include directives boosting the Affordable Care Act exchanges, coordinating the government’s COVID-19 ...
The results will support the company’s application for expanded labeling of its popular Farapulse pulsed field ablation system in a larger group of patients with atrial fibrillation.
Piéton fills an opening left by Karen Parkhill, who became HP’s CFO in August after eight years with Medtronic.
MING FONG will participate in the prestigious MD&M West trade show, bringing its cutting-edge expertise to the forefront. The company aims to showcase its one-stop service capabilities, which ...
A CergenX-led consortium, including UCC/ INFANT, was awarded €6.7 million in funding from The Disruptive Technologies Innovation Fund (DTIF), to develop CergenX Wave, an automated AI assessment to ...
CEOs from Medtronic, Intuitive Surgical, Boston Scientific and Dexcom were on hand this week in San Francisco to discuss the ...
The new director of the FDA’s device center contrasted a European rule with the U.S.’s lack of mandatory reporting ...
BD invested $10 million last year to increase manufacturing capacity. The recent expansion has created more than 200 jobs.
How the incoming Trump administration will regulate AI this year remains unclear. Meanwhile, experts say healthcare companies ...